Constant increase in aging population, bone diseases incidence, and traumatic/ accidental injuries have led to millions of orthopedic surgeries worldwide. In the USA, 280K hip, 700K vertebral, and 250K wrist fractures are treated every year. Most clinical interventions, like autografts and allografts, face challenges of rejection, significant clinical morbidity, prolonged hospitalization, delayed rehabilitation, and surgical complications. Relatively new approaches employ growth factors such as bone morphogenetic proteins (BMPs) to exert potent bone regenerative activity; however, they are limited due to serious side effects such as uncontrolled bone growth, prohibitive costs, and stability issues in the clinical setting. In the process o...